Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06998485 · ClinicalTrials.gov registry record · NA

Substrates for Post-Stroke Arm Rehabilitation

A NA study of Stroke and Stroke Rehabilitation, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06998485: Recruiting NA study of Stroke and Stroke Rehabilitation, sponsored by Massachusetts General Hospital.

NCT06998485 is a NA study of Stroke and Stroke Rehabilitation that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06998485, a NA study of Stroke and Stroke Rehabilitation, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Difficulty moving the arm is very common and a major cause of disability after stroke. Although rehabilitation therapies (i.e., occupational and physical therapy) are the most common treatments used to improve arm motor function, it remains unknown how therapy actually changes brain pathways after stroke. This project seeks to generate fundamental knowledge about brain pathways that allow people to move their arm after stroke and how these pathways change with rehabilitation; we expect this knowledge to translate to new therapies to reduce stroke-related disability. We plan to enroll N = 50 patients with moderate to severe difficulty moving their arm after ischemic or hemorrhage stroke during the subacute period (3 to 6 months post stroke) into either 30 hours over 6 weeks of Arm Basis Training (a protocolized form of occupational therapy targeting motor control) or usual care. We will perform kinematic motor assessments, neuroimaging, and neurophysiology before and after therapy in order to test the hypothesis that intensive, target training improves arm motor control and induces corresponding anatomical and physiological changes of associated brain pathways.

Primary Outcome

Kinematic measures of Upper Extremity Motor Control include joint individuation index (a measure of how well joints can move independently of other joints) and shoulder-elbow coordination (a measure of how normal a point-to-point planar reaching movement is)

Interventions

  • BEHAVIORAL Arm Basis Training

Study Locations (1)

Massachusetts

  • Laboratory for Translational Neurorecovery, Center for Neurotechnology and Neurorecovery, Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-10-07
Est. Completion 2030-04-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT06998485 shows while recruiting

NCT06998485 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Arm Basis Training is the first listed.

NCT06998485 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06998485 about?

NCT06998485 is a clinical study titled "Substrates for Post-Stroke Arm Rehabilitation". Difficulty moving the arm is very common and a major cause of disability after stroke. Although rehabilitation therapies (i.e., occupational and physical therapy) are the most common treatments used to improve arm motor function, it remains unknown how therapy actually changes brain pathways after s...

What is the current status of trial NCT06998485?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-10-07. Estimated completion is 2030-04-30.

What conditions does trial NCT06998485 study?

This clinical trial studies the following conditions: Stroke, Stroke Rehabilitation, Neurorecovery.

What interventions are being tested in trial NCT06998485?

The interventions under investigation include: Arm Basis Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT06998485?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06998485 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06998485's enrollment target sits among peer trials

50 232nd of 454 higher than 209 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06998485, the US trial registry maintained by the National Library of Medicine. NCT06998485 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.